NIH-funded research NIH-funded research

Creating a new treatment to improve vaginal health after menopause

Official title: Developing a nonsteroidal and nonhormonal agent that reverses menopause-related loss of genital epithelial integrity and function

Funded at Ohio State University · NIH-10901049 · Data updated 2026-11-12

This study is testing a new, non-hormonal treatment for postmenopausal women experiencing vaginal discomfort due to menopause, using a special peptide to help improve vaginal health and comfort over time.

More Menopause research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionOhio State University
NIH-funded
Lab location1 site (Columbus, UNITED STATES)
Project startSeptember 21, 2023
Project endAugust 31, 2025
Funding year2023
Award (this year)$391,101
NIH project number1R56AG082378-01A1
Project IDNIH-10901049 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are postmenopausal women experiencing symptoms of genitourinary syndrome.

Less likely to help

Patients who are not postmenopausal or do not experience symptoms related to genitourinary syndrome may not benefit from this research.

What this research studies

This research focuses on developing a nonsteroidal and nonhormonal treatment to address the genitourinary syndrome of menopause (GSM), which affects many postmenopausal women. The study aims to restore the integrity and function of genital epithelial tissue that deteriorates due to lower estrogen levels. By using a specially designed peptide administered intravaginally, the research will evaluate its effectiveness in improving vaginal health and safety over long-term use. The approach is based on previous findings that showed promise in animal models.

Why it matters

Potential benefit: If successful, this research could provide a safer alternative treatment for postmenopausal women suffering from vaginal irritation and related symptoms.

How similar studies have gone: Previous research has shown success with similar approaches in animal models, but this specific treatment is novel and untested in humans.

Where this research is happening

  • Ohio State University
    Columbus, United States
    Active

Researchers

  • Principal investigator: Cherpes, Thomas L. — Ohio State University
  • Study coordinator: Cherpes, Thomas L.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.